Biomed has developed a family of patented drugs for the treatment of Alzheimer’s disease, Major Depressive Disorder, Diabetes, Obesity and rare diseases including Rett Syndrome and Fragile X.
Alzheimer’s Disease: Completed a Phase 2A of NA-831 and ready for Phase 2B/3
Major Depressive Disorder: Phase 2/3 ready
Diabetes Obesity: Phase 2A ready
Rett Syndrome: Phase 2/3 ready
Fragile X: Phase 2A ready
For further information about our products, please contact us by completing an Online Contact Form. Thank you.
Learn more